Anti-VEGF antibody compositions and methods
    7.
    发明授权
    Anti-VEGF antibody compositions and methods 有权
    抗VEGF抗体组合物和方法

    公开(公告)号:US08034905B2

    公开(公告)日:2011-10-11

    申请号:US12267515

    申请日:2008-11-07

    IPC分类号: C12P21/08

    摘要: Disclosed are human antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two primary VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present invention thus provides new human antibody-based compositions, methods and combined protocols for treating cancer and other angiogenic diseases. Advantageous immunoconjugate compositions and methods using the new VEGF-specific human antibodies are also provided.

    摘要翻译: 公开了特异性抑制VEGF仅与两种主要VEGF受体中的一种(VEGFR2)结合的人抗体。 抗体有效抑制血管生成并诱导肿瘤消退,但由于其特异性而具有改善的安全性。 因此,本发明提供了新的基于人抗体的组合物,用于治疗癌症和其它血管生成疾病的方法和组合方案。 还提供了有利的免疫缀合物组合物和使用新的VEGF特异性人抗体的方法。